These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 1651190
1. SPECT in the diagnosis of Alzheimer's disease and multi-infarct-dementia. Weinstein HC, Haan J, van Royen EO, Derix MM, Lanser JB, van der Zant F, Dunnewold RJ, van Kroonenburgh MJ, Pauwels EK, van der Velde EA. Clin Neurol Neurosurg; 1991; 93(1):39-43. PubMed ID: 1651190 [Abstract] [Full Text] [Related]
2. Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. Battistin L, Pizzolato G, Dam M, Ponza I, Borsato N, Zanco PL, Ferlin G. Eur Neurol; 1990; 30(5):296-301. PubMed ID: 2269322 [Abstract] [Full Text] [Related]
3. Neuropsychological tests and [99mTc]-HM PAO SPECT in the diagnosis of Alzheimer's dementia. Villa G, Cappa A, Tavolozza M, Gainotti G, Giordano A, Calcagni ML, De Rossi G. J Neurol; 1995 Jun; 242(6):359-66. PubMed ID: 7561963 [Abstract] [Full Text] [Related]
4. A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia. Gemmell HG, Sharp PF, Besson JA, Ebmeier KP, Smith FW. Eur J Nucl Med; 1988 Jun; 14(9-10):463-6. PubMed ID: 3265101 [Abstract] [Full Text] [Related]
6. [Alzheimer's disease: study by single photon emission tomography (Hm PAO Tc99m)]. Leys D, Steinling M, Petit H, Salomez JL, Gaudet Y, Ovelacq E, Vergnes R. Rev Neurol (Paris); 1989 Sep; 145(6-7):443-50. PubMed ID: 2799210 [Abstract] [Full Text] [Related]
7. Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia. Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Ichimiya A, Masuda K. Ann Nucl Med; 1990 Nov; 4(3):75-82. PubMed ID: 2083138 [Abstract] [Full Text] [Related]
8. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. Osimani A, Ichise M, Chung DG, Pogue JM, Freedman M. Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734 [Abstract] [Full Text] [Related]
9. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO). Hellman RS, Tikofsky RS, Van Heertum R, Coade G, Carretta R, Hoffmann RG. Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154 [Abstract] [Full Text] [Related]
10. Cerebral blood flow measured by SPECT as a diagnostic tool in the study of dementia. Gemmell HG, Sharp PF, Smith FW, Besson JA, Ebmeier KP, Davidson J, Evans NT, Roeda D, Newton R, Mallard JR. Psychiatry Res; 1989 Sep; 29(3):327-9. PubMed ID: 2532750 [No Abstract] [Full Text] [Related]
11. Single photon emission computed tomography using 99mTc-HM-PAO in the routine evaluation of Alzheimer's disease. Hurwitz TA, Ammann W, Chu D, Clark C, Holden J, Brownstone R. Can J Neurol Sci; 1991 Feb; 18(1):59-62. PubMed ID: 2036616 [Abstract] [Full Text] [Related]
12. Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography. Goulding P, Burjan A, Smith R, Lawson R, Snowden J, Northen B, Neary D, Testa H. Eur J Nucl Med; 1990 Feb; 17(1-2):77-82. PubMed ID: 2083546 [Abstract] [Full Text] [Related]
13. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions. Smith FW, Besson JA, Gemmell HG, Sharp PF. J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469 [Abstract] [Full Text] [Related]
14. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Jonker C. Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952 [Abstract] [Full Text] [Related]
15. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB. J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168 [Abstract] [Full Text] [Related]
16. The value of HMPAO SPECT scanning in the diagnosis of early Alzheimer's disease in patients attending a memory clinic. McMurdo ME, Grant DJ, Kennedy NS, Gilchrist J, Findlay D, McLennan JM. Nucl Med Commun; 1994 Jun; 15(6):405-9. PubMed ID: 8078635 [Abstract] [Full Text] [Related]
17. A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. Curran SM, Murray CM, Van Beck M, Dougall N, O'Carroll RE, Austin MP, Ebmeier KP, Goodwin GM. Br J Psychiatry; 1993 Aug; 163():155-65. PubMed ID: 8075905 [Abstract] [Full Text] [Related]
18. A study of regional cerebral blood flow using 99mTc-HMPAO-SPECT in elderly women with senile dementia of Alzheimer's type. Elmståhl S, Siennicki-Lantz A, Lilja B, Bjunö L. Dementia; 1994 Aug; 5(6):302-9. PubMed ID: 7866483 [Abstract] [Full Text] [Related]
19. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. McKeith IG, Bartholomew PH, Irvine EM, Cook J, Adams R, Simpson AE. Br J Psychiatry; 1993 Nov; 163():597-603. PubMed ID: 8298827 [Abstract] [Full Text] [Related]
20. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. Perani D, Di Piero V, Vallar G, Cappa S, Messa C, Bottini G, Berti A, Passafiume D, Scarlato G, Gerundini P. J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]